AnPac Bio Announces Filing of Annual Report on Form 20-F for 2020
April 30 2021 - 4:45PM
AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) (“AnPac Bio” or
the “Company”), a biotechnology company with operations in China
and the United States focused on early cancer screening and
detection, announced today that it has filed its annual report on
Form 20-F for the fiscal year ended December 31, 2020 with the U.S.
Securities and Exchange Commission (the “SEC”) on April 30, 2021.
The Company’s annual report on Form 20-F, which contains its
audited consolidated financial statements, can be accessed on and
downloaded from the SEC’s website at www.sec.gov as well as on the
Company’s investor relations website at
https://www.anpacbio.com.
About AnPac Bio
AnPac Bio is a biotechnology company focused on early cancer
screening and detection, with 142 issued patents as of March 31,
2021. With two certified clinical laboratories in China and one
CLIA and CAP accredited clinical laboratory and one CLIA registered
clinical laboratory in the United States, AnPac Bio performs a
suite of cancer screening and detection tests, including CDA
(Cancer Differentiation Analysis), bio-chemical, immunological, and
genomics tests. According to Frost & Sullivan, AnPac Bio ranked
third worldwide among companies offering next-generation early
cancer screening and detection technologies in terms of the number
of clinical samples for cancer screening and detection, based on
approximately 41,700 clinical samples as of December 2019. AnPac
Bio’s CDA technology platform has been shown in retrospective
validation studies to be able to detect the risk of over 20
different cancer types with high sensitivity and specificity.
For more information, please visit:
https://www.Anpacbio.com.
For investor and media inquiries, please
contact:
Company:Phil Case, Marketing and Investor RelationsPhone:
+1-267-810-6776 (US)Email: phil_case@AnPacbio.com
Investor Relations:Ascent Investor Relations LLCTina Xiao,
PresidentPhone: +1-917-609-0333 (US)Email:
tina.xiao@ascent-ir.com
AnPac Bio Medical Science (NASDAQ:ANPC)
Historical Stock Chart
From Mar 2024 to Apr 2024
AnPac Bio Medical Science (NASDAQ:ANPC)
Historical Stock Chart
From Apr 2023 to Apr 2024